Updated:
Amneal Pharmaceuticals LLC
Amneal is a U.S.-based biopharmaceutical company. We are expanding access to safe, effective and affordable medicines.
Amneal Pharmaceuticals LLC
Amneal is a U.S.-based biopharmaceutical company. We are expanding access to safe, effective and affordable medicines.
General information
Firm type
Single Family Office
Year founded
2002
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bridgewater
Corporate office
Bridgewater, New Jersey, United States
Principals
Chirag Patel
Co-CEO and Co-Founder
Chintu Patel
Co-CEO and Co-Founder
Kanu Patel
Founder's father and inspiration
Sector focus
Frequently asked questions
Who runs investment decisions at Amneal Pharmaceuticals?
Chirag and Chintu Patel serve as Co-CEOs and Co-Founders, and jointly run the company. The Patel family has maintained control since founding in 2002, with both brothers actively involved in strategy and operations (per Amneal's website).
How is Amneal structured as a family-controlled public company?
Amneal is publicly traded on the NYSE under ticker AMRX, but the Patel family retains significant control as founders and co-CEOs. This structure allows access to public capital while maintaining family strategic direction.
What investment stages and asset classes does Amneal pursue?
Amneal develops and commercializes generic pharmaceuticals, specialty branded drugs, biosimilars, and injectable medicines. It also operates a distribution segment, AvKARE, serving government and institutional customers.
Which sectors does Amneal explicitly avoid?
Amneal's public materials do not list explicit avoidance criteria, but the company focuses exclusively on pharmaceutical and healthcare products — no technology, real estate, or financial services investments have been disclosed.
Does Amneal participate in external fund commitments?
As a publicly traded biopharmaceutical company, Amneal does not operate as an investment fund. The company reinvests cash flow into R&D, manufacturing, and acquisitions. No external fund commitments or direct co-investment structures have been disclosed.
Where does the Patel family wealth originate?
The wealth originates from founding and building Amneal Pharmaceuticals. Chirag and Chintu Patel started the company in 2002, built it into a global biopharma enterprise, and took it public. Their father Kanu Patel was an industrial pharmacist and regulatory inspector in India.
Does Amneal maintain philanthropic structures?
The Patel family has a foundation that supports community health and education, though specific financial details are not publicly disclosed. The company also has a corporate social responsibility program focused on patient access.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: